Meet Maithili Life Sciences at the FCE Pharma Event in Brazil : Booth G-140
At Maithili Life Sciences, we are proud to be at the forefront of API (Active Pharmaceutical Ingredient) manufacturing in India, supplying the global pharmaceutical industry with high-quality, cost-effective ingredients. With a commitment to innovation, excellence, and customer satisfaction, we are excited to announce our participation at the upcoming FCE Pharma event in São Paulo, Brazil, from June 4th to 6th, 2024. You can find us at booth No. G-140.
About Us: Maithili Life Sciences is a trusted name in the pharmaceutical industry, known for our dedication to producing APIs and intermediates that meet the highest quality standards. With state-of-the-art manufacturing facilities and a team of experienced professionals, we have established ourselves as a leading supplier to markets around the world.
Our Presence in the Brazilian Market: In recent years, Maithili Life Sciences has made significant strides in expanding our presence in the Brazilian market. Brazil, being one of the largest pharmaceutical markets in Latin America, presents immense opportunities for growth and development. Recognizing this potential, we have strategically invested in strengthening our foothold in the region.
Why Choose Maithili Life Sciences?
- Quality Assurance: Quality is at the core of everything we do. Our manufacturing processes adhere to stringent quality standards, ensuring that our products consistently meet regulatory requirements.
- Innovative Solutions: We continuously strive to innovate and develop new products to meet the evolving needs of our customers. Our R&D team is dedicated to exploring new technologies and methodologies to enhance our product offerings.
- Cost-Effectiveness: We understand the importance of cost-effectiveness in today’s competitive market. Through efficient production processes and economies of scale, we are able to offer competitive pricing without compromising on quality.
- Customer-Centric Approach: At Maithili Life Sciences, we prioritize customer satisfaction above all else. We work closely with our clients to understand their specific requirements and tailor our solutions to meet their needs.
- Reliability and Timely Delivery: With our robust supply chain and logistics network, we ensure timely delivery of products to our customers, minimizing lead times and reducing the risk of stockouts.
Our Product Portfolio: Our extensive product portfolio includes a wide range of APIs and intermediates across various therapeutic categories, including but not limited to:
| Key Intermediates | DMF STATUS | Filing | |
|---|---|---|---|
| Azilsartan Medoxomil Potassium Salt | 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid, [147403-03-0], Azilsartan Base | DMF Available | KDMF Filing |
| Benazepril HCl | 3-Bromo-2,3,4,5-tetrahydro-2-h-1-benzacepin–2one [86499-96-9], tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate[109010-60-8] | ||
| Brivaracetam | (R)-4-Propyldihydrofuran-2(3H)-one [63095-51-2] | ||
| Cabergoline Intermediates | Cabergoline Acid | ||
| Dabigatran Etexilate Mesylate | Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate [212322-56-0] | DMF Avaialble | CEP Filing |
| Dapoxetine HCl | 3-(Napthalen-1-yloxy)-1- phenylpropan-1-ol [908291-72-5], Dapoxetine Base [119356-77-3] | DMF Avaialble | |
| Darolutamide Intermediates | 4-Bromo-2-Chlorobenzonitrile | ||
| Etoricoxib | 1-(6-Methylpyridin-3-Yl)-2-[4- (Methylsulfonyl)Phenyl] Ethanone [Ketosulfone] [221615-75-4], 2-Chloro-1,3-Bis(Dimethylamino) Trimethinium Hexafluoro Phosphate [249561-98-6] | ||
| Favipiravir | 6-chloro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt [1137606-74-6] | DMF Avaialble | |
| Irbesartan | 2-Butyl-1,3-Diazaspiro-[4,4]Non-1-en-4-one hydrochloride (Spiro) [151257-01-1] | ||
| Minoxidil | 4-Chloro-2,6-Diamino-Pyrimidine [156-83-2] | ||
| Modafinil | - | ||
| Naftidrofuryl Oxalate | 1-(tetrahydro-2-furyl)-3-(1-naphthyl) propane-2-carboxylic acid (60% in toluene) [5379-26-4] | DMF Avaialble | CEP Filing |
| Nebivolol HCl | ISOMER A [793669-26-8], ISOMER B [876514-31-7] | DMF Avaialble | CEP Filing |
| Ornidazole | - | DMF Avaialble | |
| Rasagiline Mesylate | 1-Aminoindane HCl [70146-15-5] (R)-(-)-1-Aminoindane HCl [10305-73-4] | DMF Avaialble | KDMF/JDMF Filing |
| Solifenacin Succinate | 3-Quinuclidinone HCl [1193-65-3], R-(-)-3-Quinuclidinol [25333-42-0], S-1-Phenyl 1,2,3,4 tetrahydro isoquinoline [118864-75-8] | DMF Avaialble | |
| Sumatriptan Succinate | 4-Hydrazino-n-methane benzene methane sulphonamide HCl [88933-16-8], Sumatriptan Base [103628-46-2] | DMF Avaialble | CEP/KDMF/ANVISA Filing |
| Tadalafil | (1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride[171752-68-4] | DMF Avaialble | |
| Tamsulosin | Tamsulosin Base [106133-20-4] | ||
| Telmisartan | 2-n-Propyl-4-methyl-6-(1-methylbenzimidaole-2-yl) benzimidazole [152628-02-9] | ||
| Ticagrelor | 4,6-Dichloro-2-propylthiopyrimidine-5-amine [145783-15-9] | DMF Avaialble | |
| Torsemide | |||
| Trazodone | 1-(3-chlorophenyl)-4-(3-chloropropyl)-Piperazine [52605-52-4], 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one [6969-71-7] | DMF Avaialble | ANVISA Filing |
| Vardenafil | |||
| Voriconazole | - | DMF Avaialble | |
| Zaltoprofen | 5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid [83237-49-4] | JDMF/KDMF Filing |
Contact Us: For more information about Maithili Life Sciences and our products, please contact us at [email protected] or visit our website www.maithililifesciences.com.
Join us in shaping the future of pharmaceutical manufacturing! Maithili Life Sciences – Where Innovation Meets Excellence.